EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk stratification and management of non‐muscle‐invasive bladder cancer: A physician survey in six Asia‐Pacific territories

Ja Hyeon Ku iD, Lui Shiong Lee iD, Tzu-Ping Lin, Eiji Kikuchi iD, Hiroshi Kitamura, Chi-Fai Ng iD, Junice Yi Siu Ng, Darren Ming-Chun Poon, Ravindran Kanesvaran, Ho Kyung Seo, Carmel Spiteri, Ee Min Tan iD und 3 weitere

International Journal of Urology · 2024

DOI: 10.1111/iju.15309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, 2024. Verfasst von Ja Hyeon Ku und 14 weiteren Autor:innen. Beteiligte Einrichtung: Seoul National University, Seoul, South Korea. Hauptthemen laut MEDLINE: Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MSD International GmBH (Singapore).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Multiple clinical practice guidelines, conflicting evidence, and physician perceptions result in variations in risk stratification among patients with non‐muscle‐invasive bladder cancer (NMIBC). This study aims to describe the extent of this variation and its impact on management approaches in the Asia‐Pacific region.

Methods

We conducted a cross‐sectional survey involving 32 urologists and seven medical oncologists with ≥8 years of experience managing early‐stage bladder cancer patients across Australia, Hong Kong, Japan, South Korea, Singapore, and Taiwan. The physicians completed an anonymous questionnaire that assessed their risk stratification and respective management approaches, based on 19 NMIBC characteristics. For each NMIBC characteristic, they were required to select one risk group, and their most preferred management approach.

Results

Our results demonstrated a higher consensus on risk classification versus management approaches. More than 50% of the respondents agreed on the risk classification of all NMIBC characteristics, but 42% or fewer chose the same treatment option as their preferred choice for all but two characteristics—existence of variant histology (55%) and persistent high‐grade T1 disease on repeat resection (52%). Across territories, there was the greatest variation in preferred treatment options (i.e., no treatment, intravesical chemotherapy, or Bacillus Calmette‐Guérin [BCG] treatment) for intermediate‐risk patients and the highest consensus on the treatment of very high‐risk patients, namely radical cystectomy.

Conclusions

Our study revealed considerable variation in risk stratification and management of NMIBC in the region. It is critical to develop practical algorithms to facilitate the recognition of NMIBC and standardize the treatment of NMIBC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-Muscle Invasive Bladder NeoplasmsUrinary Bladder NeoplasmsHumansCross-Sectional StudiesAdministration, IntravesicalUrologistsSurveys and QuestionnairesRisk AssessmentHong KongBCG VaccineNeoplasm InvasivenessAdjuvants, ImmunologicNeoplasm Recurrence, Local

Stichwörter der Autor:innen

NMIBCclinical practicephysiciansurveytreatment guidelines

Substanzen

BCG VaccineAdjuvants, Immunologic

Autor:innen und Institutionen

  • Seoul National University, Seoul, South Korea.
  • Seng Kang General Hospital, Singapore, Singapore.
  • Taipei Veterans General Hospital, Taipei, Taiwan.
  • St Marianna University School of Medicine, Kawasaki, Japan.
  • University of Toyama, Toyama, Japan.
  • The Chinese University of Hong Kong, Hong Kong, Hong Kong.

ORCID-Profile: Ja Hyeon Ku, Lui Shiong Lee, Eiji Kikuchi, Chi-Fai Ng, Ee Min Tan

Förderung

  • MSD International GmBH (Singapore)

Zitieren

APA

Ku, J. H., Lee, L. S., Lin, T. P., Kikuchi, E., Kitamura, H., Ng, C. F., Ng, J. Y. S., Poon, D. M., Kanesvaran, R., Seo, H. K., Spiteri, C., Tan, E. M., Tran, B., Tsai, Y. S., & Nishiyama, H. (2024). Risk stratification and management of non‐muscle‐invasive bladder cancer: A physician survey in six Asia‐Pacific territories. International Journal of Urology. https://doi.org/10.1111/iju.15309

Vancouver

Ku JH, Lee LS, Lin TP, Kikuchi E, Kitamura H, Ng CF, et al. Risk stratification and management of non‐muscle‐invasive bladder cancer: A physician survey in six Asia‐Pacific territories. International Journal of Urology. 2024. doi:10.1111/iju.15309

BibTeX
@article{Ku2024,
  author = {Ku, Ja Hyeon and Lee, Lui Shiong and Lin, Tzu-Ping and Kikuchi, Eiji and Kitamura, Hiroshi and Ng, Chi-Fai and Ng, Junice Yi Siu and Poon, Darren Ming-Chun and Kanesvaran, Ravindran and Seo, Ho Kyung and Spiteri, Carmel and Tan, Ee Min and Tran, Ben and Tsai, Yuh-Shyan and Nishiyama, Hiroyuki},
  title = {Risk stratification and management of non‐muscle‐invasive bladder cancer: A physician survey in six Asia‐Pacific territories},
  journal = {International Journal of Urology},
  year = {2024},
  doi = {10.1111/iju.15309}
}
Kostenlos starten →